Redefining HPAPI manufacturing: From niche containment to integrated molecular engineering
Jean-François Carniaux of Piramal Pharma Solutions looks at the
demands the evolution of HPAPI manufacture is placing on CDMOs pational exposure, banding and typical containement strate
The global landscape for high potency( HPAPIs) is undergoing a fundamental transformation. What was once a niche segment of the pharmaceutical industry has matured into a primary driver of innovation, fuelled by the explosive growth of targeted therapeutics such as antibodydrug conjugates( ADCs) and personalised oncology treatments. The demand for ultra-high containment and specialised chemistry has never been greater.
For CDMOs, this evolution requires moving beyond standard high containment. Today’ s market demands a seamless integration of molecular engineering, realtime analytical monitoring and sophisticated supply chain resilience strategies like‘ China Plus One.’
The chemistry of potency
The shift toward highly targeted therapies has changed the very nature of HPAPI synthesis. Historically, early-phase development often relied on using toxic payloads as raw building blocks. Modern strategies, however, prioritise‘ clever design’ to limit the number of highly potent intermediates.
In the ADC sector— which is expanding at a nearly 20 % CAGR— the focus has shifted to the payloadlinker, the chemical bridge connecting a targeting antibody to a cytotoxic payload. Innovation now centres on:
• Linker stability: Developing cleavable linkers that respond to specific biological triggers in the tumour microenvironment while remaining stable in circulation
• Site-specific conjugation: Enhancing consistency in the drug-to-antibody ratio to improve both efficacy and manufacturability
While oncology remains the dominant force, emerging opportunities are appearing in chronic disease management and hormonal treatments. This includes a significant uptick in APIs offering high selectivity and these are increasingly used in personalised cancer vaccines. CDMOs are adapting by expanding capabilities in complex purification techniques like highperformance liquid chromatography( HPLC) to handle the unique physical characteristics of these newgeneration payloads.
Band 6, Extremely hazardous: isolators, split valves, glove boxes
Band 5, Very highly hazardous: isolators, dedicated equipment
Band 4, Highly hazardous: isolators, drum containment, continuous liners
Band 3, Hazardous: laminar flow booths
Band 2, Moderately hazardous: down flow booths
Band 1, Low hazard: open systems
Containment 2.0 & Industry 4.0
As payloads become increasingly potent— with some occupational exposure limits( OELs) falling to 10 ng / m 3— the industry has shifted from the traditional occupational exposure band( OEB) standard of five bands to a sixband( ultra-potent) standard( Figure 1). Modern facilities are also using such advanced hardware as:
• Barrier isolation systems: Multistage isolators with automated transfer systems to minimise human intervention
• Advanced dust-free transfers: Preventing particulate migration during the handling of dry potent powders
• Pressure cascades: Sophisticated HVAC designs that ensure that air flows from clean areas toward highcontainment zones, maintaining negative pressure within the production suites
28 SPECIALITY CHEMICALS MAGAZINE ESTABLISHED 1981